NCT07367529 2026-01-26
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Not yet recruiting
Clinical Trials
9 trialsNCT07229599 2025-11-17
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT06945523 2025-06-04
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06992583 2025-05-28
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT06768151 2025-01-10
A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer
Chongqing Precision Biotech Co., Ltd
Phase 1 Recruiting
NCT04672356 2023-06-22
A Study to Evaluate the Safety , Tolerability and Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT04672369 2023-06-22
A Study to Evaluate the Efficacy of IBI939 in Combination With Sintilimab in Patients With Advanced NSCLC
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed
NCT05431569 2022-06-24
A Phase IIa Study to Evaluate the Efficacy and Safety of 6MW3211 in Patients With Advanced Lung Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 2 Unknown
NCT03751592 2018-11-26
Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer
Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd
Phase 1/2 Unknown